Author:
Pei Qi,Peng Jinfu,Tan Hongyi,Yang Liu,Yang Xiding,Liu Li,Liu Shikun,Yuan Hong,Yang Guoping
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference25 articles.
1. Abduljalil K, Frank D, Gaedigk A, Klaassen T, Tomalik-Scharte D, Jetter A et al (2010) Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmacokinetics of dextromethorphan. Clin Pharmacol Ther 88:643–651
2. Chou YC, Ueng YF, Chou CY, Tien JH (2005) Dimemorfan N-demethylation by mouse liver microsomal cytochrome P450 enzymes. Life Sci 77:735–745
3. Chou YC, Chung YT, Liu TY, Wang SY, Chau GY, Chi CW, Soucek P et al (2010) The oxidative metabolism of dimemorfan by human cytochrome P450 enzymes. J Pharm Sci 99:1063–1077
4. European Medicines Agency (2010) Guideline on Validation of Bioanalytical Methods. Committee for Medical Products for Human Use. European medicines agency. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf . Accessed 6 Aug 2014
5. Han KM, Chang HS, Choi IK, Ham BJ, Lee MS (2013) CYP2D6 P34S polymorphism and outcomes of escitalopram treatment in Koreans with major depression. Psychiatry Investig 10:286–293
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献